Insmed to Present at the JMP Securities Life Sciences Conference
June 13 2017 - 8:00AM
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical
company focused on the unmet needs of patients with rare diseases,
announced today that Will Lewis, president and chief executive
officer of Insmed, will present at the JMP Securities Life Sciences
Conference in New York, NY on Tuesday, June 20, 2017 at 3:30 p.m.
ET.
Mr. Lewis’ presentation will be webcast live and can be accessed
by visiting the investor relations section of the company’s website
at www.insmed.com. The webcast will be archived for a period of 90
days following the conclusion of the live event.
About Insmed
Insmed Incorporated is a global biopharmaceutical company
focused on the unmet needs of patients with rare diseases. The
company is advancing a global phase 3 clinical study of ARIKAYCE®
(liposomal amikacin for inhalation) for adult patients with
treatment refractory nontuberculous mycobacteria (NTM) lung disease
caused by Mycobacterium avium complex (MAC), which is a rare and
often chronic infection that is capable of causing irreversible
lung damage and can be fatal. There are currently no approved
inhaled products specifically indicated for the treatment of
refractory NTM lung disease caused by MAC in the United States or
the European Union. Insmed's earlier-stage clinical pipeline
includes INS1007, a novel oral reversible inhibitor of DPP1 with
therapeutic potential in non-cystic fibrosis bronchiectasis, and
INS1009, an inhaled nanoparticle formulation of a treprostinil
prodrug that may offer a differentiated product profile for rare
pulmonary disorders, including pulmonary arterial hypertension. For
more information, visit www.insmed.com.
"Insmed" and "ARIKAYCE" are the company's trademarks. All other
trademarks, trade names or service marks appearing in this press
release are the property of their respective owners.
Investor Contact:
Laura Perry or Heather Savelle
Argot Partners
212-600-1902
laura@argotpartners.com
heather@argotpartners.com
Insmed (NASDAQ:INSM)
Historical Stock Chart
From Apr 2024 to May 2024
Insmed (NASDAQ:INSM)
Historical Stock Chart
From May 2023 to May 2024